Eli Lilly and Walmart to Provide Affordable Insulin

Shares

Eli Lilly and Company announced they’re teaming up with Walmart to provide an affordable insulin option for people with diabetes.
Beginning in mid-September, Lilly’s Humulin(R) brand of insulin will be available in Walmart pharmacies across the U.S. under the dual-branded name Humulin(R) ReliOn(R), including 10 mL vials of Humulin(R) R U-100, Humulin(R) N, and Humulin(R) 70/30 formulations.

Humulin, the world’s first synthetic human insulin, was introduced by Lilly in 1982.

4
Leave a Reply

avatar
3000
4 Comment threads
0 Thread replies
0 Followers
 
Most reacted comment
Hottest comment thread
4 Comment authors
Ruth MillerLeeDave SDaniel Haszard Recent comment authors
  Subscribe  
newest oldest most voted
Notify of
Ruth Miller
Ruth Miller

I use Humulin R 500 and am in the donut hole. I have a co-pay of over $500 for a $1400 vial at the pharmacy. That is every month.

Lee
Lee

In 2013 I was in Belgium when I had to buy a vial of Lily humalog. I paid under $30.00 at a pharmacy.  So why the inflated insurance cost of over $140.00 per vial. Why such a scam on prices???
Seems like insurance companies are a real scham when it comes to supposed coverage for the average person.
America maybe a great country but there seems no protection for those of us that keeps the country working.
Very discouraging!! 

Dave S
Dave S

Eli Lilly Cares…yeah you bet, At Walmart I pay 128.50 for a 10ml vial of Humalog, I just returned from Mexico where I pay $39.40 for the very same thing, only labeled in Spanish.  So tell me how much Eli Lilly and walmart cares….all the way to the bank, and the lantus is just the same way!   Both these companies are stealing from me myself over 300.00 a month for my health care.  So when I’m in the donut hole or the deductable months I can’t afford the medicine. This a great big fraud and attempt to fix prices between… Read more »

Daniel Haszard

Eli Lilly promotes sales of their #1 drug (Zyprexa $4.8 billion per year) that can *cause* diabetes and then turns around and makes billions selling more drugs to treat the diabetes.
Lilly’s cash cow Zyprexa has been over-prescribed and linked to a 10-times greater risk of causing type 2 diabetes and increased risk of heart attack.
Daniel Haszard Zyprexa whistle-blower http://www.zyprexa-victims.com

Copyright © 2009-2018 Diabetes Media Foundation, All Rights Reserved.
ASweetLife™ is a trademark of the Diabetes Media Foundation, All Rights Reserved.